T1	Participants 42 98	Southeastern Cancer Study Group experience, 1979 to 1983
T2	Participants 157 287	20 phase I, II, and III clinical trials from 1979 to 1983 at 30 member institutions of the Southeastern Cancer Study Group (SECSG)
T3	Participants 398 412	1,087 patients
